Skip to main content

Hepatitis A Pediatric Vaccine Dosage

Medically reviewed by Last updated on Dec 14, 2021.

Applies to the following strengths: 25 units/0.5 mL; 720 units/0.5 mL; 720 units/0.5 mL preservative free

Usual Pediatric Dose for Hepatitis A Prophylaxis

1 year and older: 0.5 mL intramuscularly

  • Administer a booster 0.5 mL dose 6 to 18 months after the first dose

  • Administer in the deltoid region in children 2 years and older.
  • Administer in the anterolateral aspect of the thigh in younger children.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available



  • Hypersensitivity to any of the ingredients including neomycin
  • Hypersensitivity to previous hepatitis A vaccination

Safety and efficacy have not been established in patients younger than 1 year.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at:

Consult WARNINGS section for additional precautions.


Data not available.

Other Comments

Administration advice:

  • For intramuscular use only.
  • Do not administer in the gluteal area as a suboptimal response may occur.
  • Do not administer intravenously, intradermally, or subcutaneously.
  • Primary immunization should be given at least 2 weeks prior to expected exposure to hepatitis A.

Storage requirements:
  • Refrigerate; do not freeze

Reconstitution/preparation techniques:
  • Shake well before use.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.